Status:
COMPLETED
Eye and Immunogenetic Features of Sarcoidosis
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Sarcoidosis
Uveitis
Eligibility:
All Genders
6+ years
Brief Summary
This study will evaluate patients with sarcoidosis to understand how the disease affects the body. Sarcoidosis is a disease that results from inflammation of body tissues. The lungs, lymph nodes in th...
Detailed Description
BACKGROUND Sarcoidosis is a multi-systemic granulomatous disease. The lungs, thoracic lymph nodes, the skin and the eyes are the most commonly affected organs. Most patients with sarcoidosis present ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Participants must be at least 6 years old
- Participants must have biopsy-proven sarcoidosis
- Participant must be able to consent to participating in the protocol
- For minors, consent by an adult will be necessary
- EXCLUSION CRITERIA:
- We will exclude participants who are unable or unwilling to give blood at the designated times in the protocol
Exclusion
Key Trial Info
Start Date :
September 18 2006
Trial Type :
OBSERVATIONAL
End Date :
December 10 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00379275
Start Date
September 18 2006
End Date
December 10 2007
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892